Severe liver injury after initiating therapy with atomoxetine in two children
Two children presented with acute hepatitis after starting therapy with atomoxetine (Strattera®). In one child, no competing diagnosis could be identified, and liver injury resolved completely on withdrawal of the medication. In the second child, the evaluation was suggestive of type 1 autoimmune hepatitis; she subsequently improved with removal of atomoxetine and concomitant immunosuppressive therapy. Atomoxetine may cause clinically significant hepatotoxicity either by metabolic idiosyncrasy or by inducing autoimmune hepatitis.
Abbreviations: ADHD, Attention deficit-hyperactivity disorder , ALT, Alanine aminotransferase , A phos, Alkaline phosphatase , AST, Aspartate aminotransferase , Bili D, Direct bilirubin , Bili T, Total bilirubin , CYP, Cytochrome P450 , GGT, Gamma glutamyl transpeptidase , RUCAM, Rousell Uclaf Causality Assessment Method
To access this article, please choose from the options below
PII: S0022-3476(06)00014-X
doi:10.1016/j.jpeds.2006.01.035
© 2006 Elsevier Inc. All rights reserved.
